Oculocare’s Alleye, a mobile application was granted 510(k) clearance by the FDA for monitoring eyesight in age-related macular degeneration (AMD).

The app gives patients the ability to regularly test their eyesight and assess the progression of disease without the supervision of a doctor.

It is designed to detect and characterize visual distortion in patients with macular conditions such as AMD and diabetic retinopathy.